ORAMED PHARMACEUTICALS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 933 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 51-75 of 201 matching filings.

Per page
25
Current page
3
8-K File 001-35813

CURRENT REPORT

Filing date
14 Nov 2022
Reporting date
13 Nov 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
13 Sep 2022
Reporting date
13 Sep 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
08 Sep 2022
Reporting date
01 Sep 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
07 Jul 2022
Reporting date
07 Jul 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
04 Apr 2022
Reporting date
30 Mar 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
28 Feb 2022
Reporting date
28 Feb 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
12 Jan 2022
Reporting date
12 Jan 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
08 Dec 2021
Reporting date
07 Dec 2021
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
07 Dec 2021
Reporting date
07 Dec 2021
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
04 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
29 Oct 2021
Reporting date
29 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
01 Sep 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
31 Aug 2021
Reporting date
30 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
05 Aug 2021
Reporting date
05 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
02 Aug 2021
Reporting date
25 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
15 Jul 2021
Reporting date
14 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
16 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
25 May 2021
Reporting date
23 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
10 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
23 Mar 2021
Reporting date
23 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Mar 2021
Reporting date
18 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
04 Feb 2021
Reporting date
04 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .